Reference
Peptide library
52 peptides, each with what the substance is, what the published literature reports, and where it sits on the FDA lists that govern compounding.
These pages carry no doses, no cycle lengths and no stacks. Every study reference was resolved against PubMed and confirmed to be the paper it claims to be. Every compounding status is read from FDA's published tables rather than summarised.
Side-effect and dosing material circulating on forums is self-reported, so it is not republished here. Nothing on these pages is medical advice or a recommendation to use any substance.
Mixing calculators
Not sure you have the basics covered?
Nine questions on what to have ready before a first vial, whichever compound it is.
ACE-031
Not on either FDA listRamatercept (ActRIIB-IgG1 Fc Fusion Protein)
subcutaneous
Read the page
AOD-9604
Nomination withdrawnTyr-hGH Fragment 177-191 (Anti-Obesity Drug 9604)
subcutaneous
Read the page
ARA-290
Not on either FDA listARA-290 (Cibinetide / pHBSP / Helix B Surface Peptide)
subcutaneous
Read the page
BPC-157
Nomination withdrawnBody Protection Compound-157
subcutaneous
Read the page
BPC-157 Arginate
Not on either FDA listBPC-157 Di-L-Arginine Salt (Bepecin Arginate)
oral
Read the page
CagriSema
Not on either FDA listCagriSema (Cagrilintide + Semaglutide)
subcutaneous
Read the page
Cerebrolysin
Not on either FDA listCerebrolysin (FPF-1070)
intravenous · intramuscular
Read the page
CJC-1295
Nomination withdrawnCJC-1295 (with and without DAC)
subcutaneous
Read the page
CJC-1295 DAC
Nomination withdrawnCJC-1295 with Drug Affinity Complex (DAC:GRF)
subcutaneous
Read the page
Dihexa
Nomination withdrawnN-hexanoic-Tyr-Ile-(6)-aminohexanoic amide (PNB-0408)
oral · transdermal · subcutaneous
Read the page
DSIP
Nomination withdrawnDelta Sleep-Inducing Peptide (Emideltide)
subcutaneous
Read the page
Epithalon
Nomination withdrawnEpithalon (Epitalon / AEDG Peptide)
subcutaneous · intramuscular
Read the page
FGL
Not on either FDA listFGL (FG Loop Peptide, NCAM-Derived FGFR1 Agonist)
subcutaneous · intranasal
Read the page
Follistatin 344
Not on either FDA listFollistatin Isoform FST344
subcutaneous
Read the page
FOXO4-DRI
Not on either FDA listFOXO4 D-Retro-Inverso Peptide (Proxofim)
subcutaneous
Read the page
GHK
Not on either FDA listGlycyl-L-Histidyl-L-Lysine
topical
Read the page
GHK-Cu
Nomination withdrawnCopper Peptide GHK-Cu
subcutaneous · topical
Read the page
GHRP-2
FDA category 2Growth Hormone Releasing Peptide-2 (Pralmorelin)
subcutaneous · intravenous · intranasal
Read the page
GHRP-6
FDA category 2Growth Hormone Releasing Peptide-6
subcutaneous · intravenous · intranasal · oral
Read the page
Hexarelin
Not on either FDA listExamorelin (Hexarelin, EP-23905)
subcutaneous
Read the page
Humanin
Not on either FDA listHumanin (HN) — Mitochondrial-Derived Peptide
subcutaneous
Read the page
IGF-1 DES
Not on either FDA listdes(1-3) Insulin-like Growth Factor-1
intramuscular · subcutaneous
Read the page
IGF-1 LR3
Not on either FDA listLong R3 Insulin-like Growth Factor-1
subcutaneous · intramuscular
Read the page
Ipamorelin
FDA category 2Ipamorelin Acetate
subcutaneous
Read the page
Kisspeptin
FDA category 2Kisspeptin-10 / Kisspeptin-54 (Metastin)
subcutaneous · intravenous
Read the page
KPV
Nomination withdrawnLysine-Proline-Valine (α-MSH C-terminal tripeptide)
subcutaneous · oral · topical
Read the page
Larazotide
Not on either FDA listLarazotide Acetate (AT-1001)
oral
Read the page
Liraglutide
Not on either FDA listLiraglutide (acylated GLP-1(7-37) analog)
subcutaneous
Read the page
LL-37
Nomination withdrawnLL-37 (Cathelicidin Antimicrobial Peptide / hCAP18 C-terminal fragment)
subcutaneous · topical
Read the page
Melanotan I (Afamelanotide)
Not on either FDA listAfamelanotide ([Nle4, D-Phe7]-alpha-MSH)
subcutaneous implant
Read the page
Melanotan II
Nomination withdrawnMelanotan II (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2)
subcutaneous
Read the page
MK-677 (Ibutamoren)
FDA category 2Ibutamoren Mesylate (MK-0677, L-163,191)
oral
Read the page
MOTS-c
Nomination withdrawnMitochondrial Open Reading Frame of the 12S rRNA Type-c
subcutaneous
Read the page
Noopept
Not on either FDA listNoopept (Omberacetam, GVS-111, N-Phenylacetyl-L-prolylglycine Ethyl Ester)
oral · sublingual · intranasal
Read the page
Oxytocin
Not on either FDA listOxytocin (Pitocin)
intravenous · intramuscular · intranasal
Read the page
Palmitoyl Pentapeptide-4 (Matrixyl)
Not on either FDA listPalmitoyl-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS)
topical
Read the page
PE-22-28
Not on either FDA listPE-22-28 (Spadin Analog, Sortilin Propeptide Fragment 22-28)
intranasal · subcutaneous
Read the page
Pentosan Polysulfate (PPS)
Not on either FDA listPentosan Polysulfate Sodium
subcutaneous · intramuscular
Read the page
PT-141 (Bremelanotide)
Not on either FDA listBremelanotide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH)
subcutaneous
Read the page
Retatrutide
Not on either FDA listRetatrutide (LY3437943)
subcutaneous
Read the page
Selank
Nomination withdrawnSelank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) — Synthetic Tuftsin Analog
intranasal · subcutaneous
Read the page
Semaglutide
Not on either FDA listSemaglutide (acylated GLP-1(7-37) analog)
subcutaneous · oral
Read the page
Semax
Nomination withdrawnSemax (Met-Glu-His-Phe-Pro-Gly-Pro) — Synthetic ACTH(4-10) Analog
intranasal
Read the page
Sermorelin
Not on either FDA listSermorelin Acetate (GRF 1-29 NH₂)
subcutaneous
Read the page
SS-31 (Elamipretide)
Not on either FDA listSS-31 (Elamipretide / Forzinity / Bendavia / MTP-131)
subcutaneous
Read the page
TB-500
Nomination withdrawnThymosin Beta-4 Fragment
subcutaneous · intramuscular
Read the page
Tesamorelin
Not on either FDA listTesamorelin Acetate (TH9507)
subcutaneous
Read the page
Thymosin Alpha-1
Nomination withdrawnThymosin Alpha-1 (Thymalfasin / Zadaxin)
subcutaneous
Read the page
Thymosin Beta-4
Not on either FDA listThymosin Beta-4 (Tβ4 / Timbetasin)
subcutaneous
Read the page
Thymulin
Not on either FDA listThymulin (Facteur Thymique Sérique / FTS / Nonathymulin)
subcutaneous
Read the page
Tirzepatide
Not on either FDA listTirzepatide (dual GIP/GLP-1 receptor agonist)
subcutaneous
Read the page
VIP
Not on either FDA listVasoactive Intestinal Peptide (Aviptadil)
intranasal · intravenous · inhaled
Read the page
